Capital International, Inc. Novo Cure LTD Transaction History

Capital International, Inc.

$7.23 Billion
Q2 2024

A detailed history of Capital International, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Capital International, Inc. holds 34,205 shares of NVCR stock, worth $568,487. This represents 0.01% of its overall portfolio holdings.

Number of Shares

34,205

Previous 34,205 -0.0%

Holding current value

$568,487

Previous $534,000 9.55%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$11.13 - $15.78 $153,571 - $217,732	13,798 Added 67.61%	34,205 $510,000
Q3 2023 Nov 13, 2023	SELL	$16.15 - $42.35 $935,844 - $2.45 Million	-57,947 Reduced 73.96%	20,407 $329,000
Q2 2023 Aug 11, 2023	SELL	$40.29 - $82.51 $350,966 - $718,744	-8,711 Reduced 10.01%	78,354 $3.25 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $285,304 - $600,584	5,055 Added 6.16%	87,065 $5.24 Million
Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $149,329 - $199,253	-2,334 Reduced 2.77%	82,010 $6.02 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $2.43 Million - $3.2 Million	-35,676 Reduced 29.73%	84,344 $6.41 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $22,413 - $35,600	-396 Reduced 0.33%	120,020 $8.34 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $1.98 Million - $2.78 Million	-32,941 Reduced 21.48%	120,416 $9.98 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $671,740 - $1.09 Million	8,947 Added 6.2%	153,357 $11.5 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $509,753 - $853,685	-4,388 Reduced 2.95%	144,410 $16.8 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $3.85 Million - $6.66 Million	29,527 Added 24.76%	148,798 $33 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $544,967 - $835,036	-4,391 Reduced 3.55%	119,271 $15.8 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $540,386 - $839,006	4,818 Added 4.05%	123,662 $21.4 Million
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $2.92 Million - $5.6 Million	50,296 Added 73.37%	118,844 $13.2 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $838,723 - $1.09 Million	14,663 Added 27.21%	68,548 $4.07 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $3.07 Million - $5.16 Million	53,885 New	53,885 $3.63 Million

Others Institutions Holding NVCR

# of Institutions

265

Shares Held

78.6M

Call Options Held

751K

Put Options Held

293K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.74B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Novo Cure LTD Transaction History